Abstract. Sequencing studies have been discovering a numerous number of rare variants, allowing the identification of the effects of rare variants on disease susceptibility. As a method to increase the statistical power of studies on rare variants, several groupwise association tests that group rare variants in genes and detect associations between groups and diseases have been proposed. One major challenge in these methods is to determine which variants are causal in a group, and to overcome this challenge, previous methods used prior information that specifies how likely each variant is causal. Another source of information that can be used to determine causal variants is observation data because case individuals are likely to have more causal variants than control individuals. In this paper, we introduce a likelihood ratio test (LRT) that uses both data and prior information to infer which variants are causal and uses this finding to determine whether a group of variants is involved in a disease. We demonstrate through simulations that LRT achieves higher power than previous methods. We also evaluate our method on mutation screening data of the susceptibility gene for ataxia telangiectasia, and show that LRT can detect an association in real data. To increase the computational speed of our method, we show how we can decompose the computation of LRT, and propose an efficient permutation test. With this optimization, we can efficiently compute an LRT statistic and its significance at a genome-wide level. The software for our method is publicly available at
Introduction
Current genotyping technologies have enabled cost-effective genome-wide association studies (GWAS) on common variants. Although these studies have found numerous variants associated with complex diseases [1, 2, 3] , common variants explain only a small fraction of disease heritability. This has led studies to explore effects of rare variants, and recent studies report that multiple rare variants affect several complex diseases [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14] . However, the traditional statistical approach that tests each variant individually by comparing the frequency of the variant in individuals who have the disease (cases) with the frequency in individuals who do not have the disease (controls) yields low statistical power when applied to rare variants due to their low occurrences.
Identifying genes involved in diseases through multiple rare variants is an important challenge in genetics today. The main approach currently proposed is to group variants in genes and detect associations between a disease and these groups. The rationale behind this approach is that multiple rare variants may affect the function of a gene. By grouping variants, we may observe a larger difference in mutation counts between case and control individuals and hence, power of studies increases. Recently, several methods have been developed for the groupwise approach such as the Cohort Allelic Sums Test (CAST) [15] , the Combined Multivariate and Collapsing (CMC) method [16] , a weighted-sum statistic by Madsen and Browning (MB) [17] , a variable-threshold approach (VT) [18] , and Rare variant Weighted Aggregate Statistic (RWAS) [19] .
In combining information from multiple rare variants, a groupwise association test faces two major challenges. The first is unknown effect sizes of variants on the disease phenotype. To address this challenge, MB and RWAS discuss a disease risk model in which rarer variants are assumed to have higher effect sizes than common variants [17, 19] . This model provides a simulation framework that would be appropriate for testing the groupwise tests on rare variants because it describes associations usually not found in traditional GWAS. RWAS is shown to outperform other grouping methods under this disease risk model [19] . The second challenge is that only a subset of the rare variants in the gene will have an effect on the disease and which of these variants are causal is unknown. Including non-causal variants in a groupwise association test may reduce power because it may weaken effects of causal variants. RWAS and VT attempt to overcome this challenge by utilizing prior information of which variants are likely causal, and prior information can be obtained from bioinformatics tools such as Align-GVGD [20] , SIFT [21] and PolyPhen-2 [22] . By incorporating prior information into the methods, RWAS and VT reported that they achieved higher power [18, 19] .
These methods do not achieve the best performance even under the assumptions of their disease model (as we show below) and we improve on the previous methods by taking advantage of the following ideas. First, observational data can give us a clue to which variants are causal in data because casual variants occur more frequently in cases than in controls. Hence, a method that infers causal variants from data would outperform methods that do not, and previous methods fall into the latter category. In addition, previous methods such as RWAS, MB, and VT compute their statistics using a linear sum of mutation counts. In these methods, a large discrepancy in mutation counts between cases and controls has the same effect on a statistic as a sum of two small discrepancies with half the size of the large one. However, the large discrepancy should contribute more than the sum of small discrepancies because a variant that causes the large difference in mutation counts is more likely to be involved in a disease. To emphasize the large discrepancy, a nonlinear combination of mutation counts is necessary. Finally, the set of rare variants in the gene and their distribution among cases and controls can be used to estimate the effect sizes of the rare variants on the disease. This estimate can then be used to improve the statistical power of the method.
In this paper, we present a novel method for the groupwise association test based on a likelihood ratio test (LRT). LRT computes and compares likelihoods of two models; the null model that asserts no causal variants in a group and the alternative model that asserts at least one causal variant. To compute likelihoods of the models, LRT assumes that some variants are causal and some are not (called "causal statuses of variants") and computes the likelihood of the data under each possible causal status. This allows LRT to compute likelihoods of the null and alternative models, and a statistic of LRT is a ratio between likelihoods of the two models.
LRT takes advantage of both prior information and data to compute likelihoods of underlying models, and hence it uses more information than previous methods to identify a true model that generated data. Simulations show that LRT is more powerful than previous methods such as RWAS and VT using the same set of prior information. We also show by using real mutation screening data of the susceptibility gene for ataxia telangiectasia that LRT is able to detect an association previously reported by [23] and [19] .
Unfortunately, to compute the LRT statistic directly, we must consider a number of possible models exponential in the number of rare variants in the gene. In addition, we must perform this computation once in each permutation and we must perform millions of permutations to guarantee that we control false positives when trying to obtain genome-wide significance. We address these computational challenges by decomposing the computation of LRT and developing an efficient permutation test. Unlike the standard approach to compute the LRT statistics which requires exponential time complexity, we make a few assumptions and derive a method for computing the LRT statistic whose time complexity is linear. For the permutation test, we further decompose the LRT statistic and take advantage of the distribution of allele frequency. These techniques allow us to compute a statistic of each permutation efficiently, and hence we can perform a large number of permutations to obtain genome-wide significance. We provide the software package for LRT at http://genetics.cs.ucla.edu/rarevariants. [19] . We use c i to denote the probability of variant i being causal to a disease. Then, we can compute the prior probability of each scenario v j as
Material and Methods

Computation of Likelihoods of Haplotypes
We define L(D + , D − |v j ) as the likelihood of observing case and control haplotypes given jth scenario. Then, L 0 and L 1 can be defined as
where v 0 is a scenario where v i 0 = 0 for all variants; no causal variants. In the Appendix we describe how we can compute
, and we perform a permutation test to compute a p-value of the statistic.
Computation of Likelihoods of Variants.
We decompose L 0 and L 1 in (Equations 2, 3) such that we compute likelihoods of variants instead of likelihoods of haplotypes to reduce the computational complexity. To compute L 1 in (Equation 3), we need to compute likelihoods of 2 M scenarios of causal statuses, which is computationally expensive if there are many rare variants in a group. To decompose likelihoods of haplotypes, we make two assumptions. The first assumption is low disease prevalence, and the second assumption is no linkage disequilibrium between rare variants [16, 24, 25] .
Assume there are N/2 case and N/2 control individuals. Let 
where p
We estimate the population MAF of a variant (p i ) using an observed overall sample frequency.
represent observed case and control MAF, respectively. This decomposition reduces the time complexity of computing L 1 from exponential to linear, substantially increasing the computational efficiency.
Efficient Permutation Test for LRT.
We propose a permutation test that is substantially more efficient than a naive permutation test that permutes case and control statuses in each permutation. The naive permutation test is computationally expensive because every haplotype of case and control individuals needs to be examined in each permutation, and hence it requires more computation as the number of individuals increases. Moreover, to compute a p-value at a genome-wide level, more than 10 million permutations are necessary assuming a significance threshold of 2.5 × 10 −6 (computed from the overall false positive rate of 0.05 and the Bonferroni correction with 20,000 genes genome-wide). It is often computationally impractical to perform this large number of permutations with the naive permutation test. Hence, we develop a permutation test that does not permute case and control statuses, and this makes the time complexity independent of the number of individuals and allows the permutation test to be capable of performing more than 10 million permutations.
First, we reformulate L 0 and L 1 (Equations 4, 5) such that they are composed of terms that do not change and terms that change per each permutation (see the Appendix for the derivation).
where
In (Equations 8 and 9), it is only ap + i term that changes when the dataset is permuted because p i and p To speed up sampling from the hypergeometric distribution, we pre-compute hypergeometric distributions of all rare variants (e.g. variants whose MAF are less than 10%) before performing the permutation test. Computing the hypergeometric distribution requires several factorial operations, which is computationally expensive. The precomputation of distributions allows the permutation test to avoid having the expensive operations repeatedly per permutation, and the number of pre-computed distributions is limited due to the small range of MAF. For common variants, we sample Np + i from the normal distribution, which approximately follows the hypergeometric distribution whenp + i is not close to 0 or 1. Sampling from the normal distribution is substantially more efficient than sampling from the hypergeometric distribution, and hence there is no need to pre-compute the normal distribution.
We find that our permutation test is efficient enough to calculate a p-value of the LRT statistic at a genome-wide level. For example, using a dataset that contains 1000 cases and 1000 controls with 100 variants, 10 million permutations take about 10 CPU minutes using one core of a Quad-Core AMD 2.3 GHz Opteron Processor. Note that the time complexity of our method is O (N + kM P ) where N is the total number of individuals, M is the number of variants, P is the number of permutations, and k is the number of iterations in the local search algorithm discussed below (see "Estimating PAR of a group of variants using LRT" section for more details). We find that k is very small in permutations and M P N for a large number of permutations (e.g. 100 millions). Thus, the time complexity of our method becomes approximately O(M P ), and this shows that the amount of computation our method needs mostly depends on the number of variants and the number of permutations.
We note that our permutation test can also be applied to previous grouping methods such as RWAS [19] . RWAS assumes that its statistic (a weighted sum of z-scores of variants) approximately follows the normal distribution, and the p-value is obtained accordingly. Since the permutation test does not make any assumptions on the distribution of a statistic, it may provide a more accurate estimate of a p-value and improve the power of previous methods.
Power Simulation Framework
The effect sizes and the causal statuses of variants are two major factors that influence the power of the groupwise association test. To simulate these two factors, we adopt the same simulation framework as one discussed in Sul et al. and Madsen and Browning [17, 19] . In this framework, population attributable risk (PAR) defines the effect sizes of variants, and we assign the predefined group PAR to a group of variants. The group PAR divided by the number of causal variants is the marginal PAR, denoted as ω, and every variant has the same ω.
The effect size of a variant also depends on its population MAF in this simulation framework. We assign each variant population MAF (p i ) sampled from Wright's formula [26, 27] , and we use the same set of parameter values for the formula as discussed in Sul et al. and Madsen and Browning (see [17, 19] for details). Using ω and population MAF, we can compute relative risk of variant i (γ i ) as following.
( Equation 10) shows that a rarer variant has the higher effect size. Given relative risk and population MAF of a variant, we compute the true case and control MAF of the variant according to (Equations 6 and 7). We then use the true case and control MAF to sample mutations in case and control individuals, respectively. To simulate the causal status of a variant, we assign each variant the probability of being causal to a disease. Let c i denote this probability for variant i, and in each dataset, a variant is causal with the probability c i , and not causal with the probability 1 − c i . Relative risk of a causal variant is defined in (Equation 10 ) while that of non-causal variant is 1.
Given all parameters of variants, we generate 1,000 datasets, and each dataset has 1,000 case and 1,000 control individuals with 100 variants. Since we are interested in comparing power of the groupwise tests, we only include datasets that have at least two causal variants. The number of significant datasets among the 1,000 datasets is used as an estimate of power with the significance threshold of 2.5 × 10 −6 .
Estimating PAR of a Group of Variants Using LRT.
We need a few model parameters to compute the LRT statistic, and we use data, prior information, and the LRT statistic itself to estimate the parameters. More specifically, we need to know relative risk of variant i, γ i , to compute p
). According to (Equation 10), γ i depends on population MAF (p i ) and the marginal PAR (ω) which is the group PAR divided by the number of causal variants. We can estimate p i from observational data, and we use prior information (c i ) of variants to compute the expected number of causal variants, which we use as an estimate of the number of causal variants.
To estimate the group PAR, we use the LRT statistic because we are likely to observe the greatest statistic when LRT is given the group PAR that generated observational data. We apply a local search algorithm to find the value of PAR that maximizes the LRT statistic; we compute the statistic assuming a very small PAR value (0.1%), and iteratively compute statistics using incremental values of PAR (0.2%, 0.3%, etc.) until we observe a decrease in the LRT statistic. After we find the maximum LRT statistic, we perform the permutation test with the same local search algorithm to find the significance of the statistic.
Results
Type I Error Rate of LRT
We examine the type I error rate of LRT by applying it to "null" datasets that contain no causal variants. We measure the type I error rates under three significance thresholds; 0.05, 0.01, and 2.5×10 −6 (the significance threshold for the power simulation). A large number of null datasets are necessary to accurately estimate the type I error rate under the lowest significance threshold (2.5 × 10 −6 ). Thus, we create 10 million datasets, and each dataset contains 1000 case and 1000 control individuals with 100 variants. We estimate the type I error rate as the proportion of significant datasets among the 10 million datasets.
To efficiently measure the type I error rates of LRT, we use the following approach. We first test LRT on all 10 million datasets with 100,000 permutations. This small number of permutations makes it possible to test LRT on all null datasets and allows us to estimate the type I error rates under the 0.05 and 0.01 significance thresholds. As for the lowest significance threshold, we need to test LRT with a very large number of permutations (e.g. 100 million) to obtain a genome-wide level p-value. To reduce the amount of computation, we exclude datasets whose p-values cannot be lower than 2.5× 10 −6 with 100 million permutations. More specifically, to obtain a p-value less than 2.5 × 10 −6 , the number of significant permutations (permutations whose LRT statistics are greater than the observed LRT statistic) must be less than 250 with 100 million permutations. We exclude datasets having more than 250 significant permutations after the 100,000 permutations. We then apply the adaptive permutation test on the remaining datasets; we stop the permutation test when the number of significant permutations is greater than 250. The proportion of datasets whose permutation tests do not stop until 100 million permutations is the type error rate under the 2.5 × 10 −6 threshold. We find that the type I error rates of LRT are 0.0500946, 0.0100042, and 2.6 × 10 −6 for the significance thresholds of 0.05, 0.01, and 2.5 × 10 −6 , respectively. This shows that the type I error rates are well controlled for LRT under the three different thresholds.
Power Comparison between LRT and Previous Grouping Methods
We compare power between LRT and previous methods using two simulations. We design these simulations to observe how LRT's implicit inference of which variants are causal affects the power compared to methods which do not make this kind of inference. In the first simulation, we generate datasets in which variants have true c i = 0.1. This means that only a subset of variants is causal, and causal statuses of variants vary per datasets. In the second simulation, all 100 variants in datasets are causal; true c i of all variants is 1.
We test four different methods in this experiment; LRT, Optimal Weighted Aggregate Statistic (OWAS), MB, and VT. OWAS computes a difference in mutation counts between case and control individuals for each variant, or z-score of a variant, and assigns weights to z-scores according to the non-centrality parameters of z-scores [19] . Sul et al. reported that OWAS achieves slightly higher power than RWAS [19] . Thus, we test OWAS instead of their proposed method, RWAS, to compare power between a weighted sum of z-scores approach and the LRT approach. Since OWAS needs to know the effect sizes of variants, we give OWAS the true group PAR that generated data. OWAS divides the true group PAR by the expected number of causal variants to compute the marginal PAR (ω) and then compute relative risk of variants (Equation 10). We also apply our permutation test for LRT (see Material and Methods) to OWAS to estimate its p-value more accurately. To test VT, we use an R package available online [18] . LRT, OWAS, and VT are given prior information that is equivalent to true c i of datasets, and we perform 10 million permutations to estimate p-values of their statistics.
Results of the two simulations show that LRT outperforms the previous groupwise tests in the first simulation, and it has almost the same power as OWAS in the second simulation. In the first simulation, LRT has higher power than other tests at all group PAR values ( Figure 1A) ; at the group PAR of 5%, LRT achieves 94.5% power while OWAS and VT achieve 53.7% and 83.6% power, respectively. This shows that data may provide useful information about causal statuses of variants, and a method that takes advantage of data achieves higher power than those that do not. When prior information, however, can alone identify which variants are causal as in the second simulation, LRT and OWAS have almost the identical power ( Figure 1B) . This is because both methods know which variants are causal from prior information. Hence, this experiment demonstrates that LRT is generally a more powerful approach than the weighted sum of z-scores approach because it achieves higher power in studies where prior information cannot specify which variants are causal.
LRT on Real Mutation Screening Data of ATM
We apply LRT to real mutation screening data of the susceptibility gene for ataxia telangiectasia [23] . This gene, called ATM, is also an intermediate-risk susceptibility gene for breast cancer. Tavtigian et al. conducted mutation screening studies and collected data from 987 breast cancer cases and 1021 controls. Tavtigian et al. increased the number of cases and controls to 2531 and 2245, respectively, by collecting data from seven published ATM case-control mutation screening studies. This dataset is called "bona fide case-control studies," and 170 rare missense variants are present in this dataset. Sul et al. also analyzed the dataset with RWAS [19] .
To obtain prior information of variants in the dataset, Tavtigian el al. used two missense analysis programs, Align-GVGD [20] and SIFT [21] . A difference between the two programs is that while SIFT classifies a variant as either deleterious (SIFT scores ≤ 0.05) or neutral (SIFT scores > 0.05), Align-GVGD classifies a variant into seven grades from C0 (most likely neutral) to C65 (most likely deleterious). To convert the seven grades of Align-GVGD into c i values, we arbitrarily assign c i values from 0.05 to 0.95 in increments of 0.15 to the seven grades. As for converting SIFT scores into c i values, we assign c i value of 1 to variants whose SIFT scores are ≤ 0.05 and c i of 0 to other variants. This is the same conversion used in [19] .
When LRT uses prior information from Align-GVGD, it yields a p-value of 0.0058, which indicates a significant association between a group of rare variants and the disease. This result is consistent with the findings of [23] and [19] ; Tavtigian et al. and Sul et al. both obtained significant p-values when they used outputs of Align-GVGD as prior information. The result shows that we can apply LRT to real data to discover an association. LRT yields a non-significant p-value of 0.39341 when it does not use prior information, and this is also consistent with results of [23] and [19] ; Tavtigian et al. and Sul et al. reported non-significant p-values when they analyzed the data without prior information. When SIFT scores are used as prior information, LRT similarly reports a non-significant p-value of 0.08384, and Sul et al. also obtained a non-significant p-value [19] . However, the analysis of Tavtigian et al. with SIFT scores showed a significant association [23] . According to [19] , the reason for this difference may be that LRT and RWAS need to know the relative degree of how deleterious a variant is to better detect an association. However, it may be difficult to know this relative deleteriousness of variants with SIFT scores because variants are either deleterious or neutral. Thus, this experiment shows that more informative prior information such as the seven grades of Align-GVGD may yield better results with LRT.
Discussion
We developed a likelihood ratio test (LRT) to increase power of association studies on a group of rare variants. The power of statistical methods that group rare variants depends on which rare variants to group or to exclude from the group because including non-causal variants in the group decreases power [19] . Although prior information provides useful information of how likely each variant is casual to a disease, determining whether a variant is causal or not in data only from prior information is often infeasible. LRT takes advantage of data to identify causal variants, and when it is not possible to identify causal variants from prior information, we showed that LRT outperforms previous methods.
To evaluate LRT on real data, we used mutation screening data of the ATM gene [23] . Tavtigian et al. and Sul et al. both found the significant association in the data [23, 19] , and we showed that LRT also detected the association using the output of Align-GVGD as prior information of variants. This shows that LRT can be applied to detect an association in real association studies.
One of the two assumptions that we made to efficiently compute the LRT statistic and its p-value is the independence between variants. Several studies suggest that there would be very low linkage disequilibrium between rare variants due to their low occurrences [16, 24, 25] . However, if non-negligible LD is expected between variants, especially when common variants are in linkage disequilibrium in the group, we can change our permutation test as follows to take into account LD and to correctly control the false positive rate. Instead of separately sampling Np + i of each common variant from the normal distribution, we sample Np + i of all common variants from the multivariate normal distribution (MVN). This approach is similar to the approach of Han et al who used the MVN framework to correct for multiple testing on correlated markers [28] . The covariance matrix of the MVN we create consists of correlations (r) between common variants, and hence Np + i sampled from this MVN takes into account LD between variants. For rare variants, we use our proposed method that samples Np + i of each rare variant from the hypergeometric distribution because LD between rare variants is expected to be very low.
The other assumption of our method is the low disease prevalence, and this assumption does not influence the false positive rate of our method while it may affect the power. The false positive rate of LRT is controlled even though the disease we consider is highly prevalent because we perform the permutation test. Therefore, LRT can still be applied to association studies involving diseases with high prevalence while its power may not be as high as the power it achieves on diseases with low prevalence.
The software package for computing the LRT statistic and performing the proposed permutation test is publicly available online at http://genetics.cs.ucla.edu/rarevariants.
. Let H 0 denote the haplotype with no variants, and using Bayes' theorem and independence between H k and v j , and between disease status (+ and −) and v j , we can define the
P (+|H 0 , v j ), or the probability of having a disease given no variants in the haplotype under jth causal statuses, can be computed as 
Decomposition of Likelihoods of Haplotypes into Likelihoods of Variants in LRT
Our first assumption for decomposition is that F or disease prevalence is very small. Then, we can decompose P (H k |−, v j ) for all causal statuses j, as
Then, we decompose P (H k |+, v j ) for different v j , and first, let's consider v 11 where two variants are both causal. We make another assumption here, which is the independence between rare variants; there is no linkage disequilibrium (LD) [16, 24, 25] . If variants are independent, P (H 00 |+, v 11 ) can be formulated as P (H 00 |+, v 11 ) = P (H 00 ) P (H 00 ) + P (H 10 )γ 1 + P (H 01 )γ 2 + P (H 11 )γ 1 γ 2
The last derivation comes from (6) where p Combining these probabilities, we have the following decomposition of P (H k |+, v 11 ).
Using the similar derivation, decomposition of P (H k |+, v 01 ) and P (H k |+, v 10 ) is
